NCT04825704View on ClinicalTrials.gov

Bupivacaine in Tonsillectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

June 27, 2023

Study Completion Date

June 27, 2023

Conditions
Pain, Postoperative
Interventions
DRUG

Bupivacaine

Topical administration of bupivacaine via gauze swab in the tonsillar fossae after removal of throat tonsils.

DRUG

Sodium chloride

Topical administration of 0,9% sodium chloride via gauze swab in the tonsillar fossae after removal of throat tonsils.

Trial Locations (1)

N-8096

Nordland Hospital, Bodø

All Listed Sponsors
lead

Nordlandssykehuset HF

OTHER

NCT04825704 - Bupivacaine in Tonsillectomy | Biotech Hunter | Biotech Hunter